Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-022357
Filing Date
2025-08-06
Accepted
2025-08-06 08:20:44
Documents
51
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 595589
2 EX-31.1 ex31-1.htm EX-31.1 18147
3 EX-32.1 ex32-1.htm EX-32.1 5895
  Complete submission text file 0001641172-25-022357.txt   2980690

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20250630.xsd EX-101.SCH 26200
5 XBRL CALCULATION FILE pulm-20250630_cal.xml EX-101.CAL 36647
6 XBRL DEFINITION FILE pulm-20250630_def.xml EX-101.DEF 82514
7 XBRL LABEL FILE pulm-20250630_lab.xml EX-101.LAB 213311
8 XBRL PRESENTATION FILE pulm-20250630_pre.xml EX-101.PRE 159487
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 334373
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 251187584
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)